For patients with severe obesity-related complications, providers may lean toward therapies with the strongest efficacy data currently available
Its thought to be more effective than semaglutide in helping people lose weight, according to research published in JAMA Internal Medicine in July 2024
This superior efficacy helped it achieve global sales of ~US$16.4bn in 2024 (Mounjaro ~US$11.5bn and Zepbound ~US$4.9bn), rivalling semaglutide and completely overshadowing the sales of historical GLP-1s, such as exenatide, liraglutide and dulaglutide [FIGURE TWO]
An ALND is also called axillary dissection, axillary node dissection or axillary lymphadenectomy
Ozempic uses Type 2 diabetes mellitus Ozempic is FDA-approved as therapy to use alongside diet and exercise to control blood sugar in adults with type 2 diabetes
The cost will vary depending on insurance coverage, location, dosage strength among others